Cerevance establishes strategic research collaboration with Merck
Partnership will focus on the discovery of novel targets in Alzheimer’s disease
Read More
Tag: Cerevance
Positive results for Cerevance’s Parkinson’s drug
In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
